Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 45 (RPL21P45)

Target: RPL21P45
Molecular classification: Other (pseudogene; not an enzyme, receptor, transporter, or transcription factor)

Overview

Ribosomal protein L21 pseudogene 45 (RPL21P45) is a processed pseudogene found in the human genome.[2] It does not encode a functional protein and is not transcribed or translated into a product with known biological activity. Like other pseudogenes derived from ribosomal protein genes, it is the result of gene duplication and subsequent loss of coding potential. As such, RPL21P45 does not participate in cellular pathways, disease mechanisms, or drug responses. Information about biological function, disease involvement, drug interaction, or safety concerns pertains only to the protein-coding RPL21 gene and not to its pseudogenes.[1][2][5]

Other names: RPL21_15_469RPL21P45

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 45 (RPL21P45).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 45 (RPL21P45).

Explore the full profile